Caffeine: use and effects in long-stay psychiatric patients.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 8481748.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a double-blind crossover study of 26 long-stay schizophrenic patients, no correlation was found between caffeine consumption and levels of anxiety and depression. No significant changes in patients' behaviour or levels of anxiety and depression occurred when the wards changed to decaffeinated products. Serum caffeine levels confirmed compliance. No evidence was found to support a removal of caffeinated products from this group of patients.
Medical subject headings
- Anxiety Disorders
- Caffeine
- Depressive Disorder
- Hospitalization
- Psychoses, Substance-Induced
- Schizophrenia
- Schizophrenic Psychology